IRIS
BIGNARDI, GAETANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.550
AS - Asia 25
SA - Sud America 2
Totale 6.577
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.549
CN - Cina 15
SG - Singapore 8
VN - Vietnam 2
BR - Brasile 1
EC - Ecuador 1
FI - Finlandia 1
Totale 6.577
Salva come PNG Salva come JPEG
Città #
Genova 3.925
Genoa 1.547
Rapallo 621
Vado Ligure 439
Bordighera 17
Beijing 6
Bauru 1
Hanoi 1
Ho Chi Minh City 1
Manta 1
Totale 6.559
Salva come PNG Salva come JPEG
Nome #
Study of the interaction of dithranol with heptakis(2,3,6-tri-O-methyl)-b-cyclodextrin in solution and in the solid state 159
Complex extemporaneous preparations: stability study of a formulation containing diethylpropion hydrochloride in hard capsules 155
An example of application of a mixture design with constraints to a pharmaceutical formulation 151
Development and characterization of a buccoadhesive dosage form of oxycodone hydrochloride 145
A Method for the production of bioadhesive compact matrices (European Patent) 145
Stability study of hard gelatin capsules containing retinoic acid 140
A method for the production of bioadhesive compact matrices (Japanese Patent) 140
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES (US Patent) 139
Study of retinoic acid polymorphism 136
A new carrier for cisplatin: nanoparticles deriving from the interaction between N-trimethyl glycol chitosan and poly-L-glutamate 136
STABILITY INDICATING HPLC ASSAY FOR RETINOIC ACID IN HARD GELATINE CAPSULES CONTAINING LACTOSE AND AS BULK DRUG SUBSTANCE 133
Development, characterization and preliminary clinical evaluation of mucoadhesive vaginal gels containing chlorhexidine digluconate 130
Median-based robust regression methods in prediction of drug stability 130
A Chitosan-Poloxamer 407 Matrix for Buccal Drug Delivery. 127
Optimization of cross-linked high amylose starch microspheres containing 5-fluorouracil 127
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES THAT CAN BE USED EITHER AS SUCH OR FOR THE PROLONGED RELEASE OF ACTIVE SUBSTANCES, AND COMPACT MATRICES THUS OBTAINED 127
Poloxamer 407 as a solubilising agent for tolfenamic acid and as a base for a gel formulation 126
Preparation and evaluation of a chitosan salt–poloxamer 407 based matrix for buccal drug delivery 126
Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex 125
A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES (China Patent) 121
Cisplatin delivery: a study on a cisplatin-hyaluronate complex and nanoparticles formed by its interaction with N-trimethyl chitosan 120
Characterisation and in vitro evaluation of biological activity of retinoic acid complexes with some bile salts 120
PROCEDE POUR LA FABRICATION DE MATRICES COMPACTES BIOADHESIVES QUI PEUVENT ETRE UTILISEES SOIT EN TANT QUE TELLES, SOIT POUR LA LIBERATION PROLONGEE DE SUBSTANCES ACTIVES ET MATRICES COMPACTES AINSI OBTENUES A METHOD FOR THE PRODUCTION OF BIOADHESIVE COMPACT MATRICES THAT CAN BE USED EITHER AS SUCH OR FOR THE PROLONGED RELEASE OF ACTIVE SUBSTANCES, AND COMPACT MATRICES THUS OBTAINED (Canadian Patent) 118
Cycloaddition of dichloroketene to N,N-disubstituted 3-aminomethylene-5-hydroxy- 2,2-dimethyl-7-pentyl-4-chromanone: synthesis of 2H,5H-pyrano[3,2-c][1] benzopyran derivatives 117
Identification of degradation products of Ibuprofen arising from oxidative and thermal treatments 117
A Method for the production of bioadhesive compact matrices (Russian Patent) 116
Optimization of cross-linked high amylose starch microspheres containing 5-fluorouracil 114
Chitosan-Alginate Nanoparticles Containing Cisplatin Complexed With Alginate 111
A Method for the production of bioadhesive compact matrices 111
Metodo di produzione di matrici compatte bioadesive impiegabili come tali o per il rilascio controllato di sostanze attive e matrici compatte così ottenute. 109
Identificazione di nuovi prodotti di degradazione dell'ibuprofene. 108
Aspetti preliminari di uno studio preformulativo riguardante l'acido retinoico. 105
Applicazione del metodo di regressione robusta MBWR nella previsione di shelf life: stabilità di capsule contenenti acido retinoico. 104
"Valutazione in vitro della bioadesività di forme di dosaggio boccali" 104
Development and in vitro evaluation of buccoadhesive tablets using a new model substrate for bioadhesion measures: the eggshell membrane 100
Preparation and evaluation of N-trimethyl chitosan/alginate nanoparticles containing cisplatin complexed with alginate 98
Hemolytic Action and Surface Activity of Triterpene Saponins from Anchusa officinalis L. 97
Modification of Drug Release from Tablets Produced By direct compression 96
Nanoparticles Formed by Interaction of Poly-L-Lysine or Chitosan With Polycarboxylic Polymers Complexed with Cisplatin 96
Solubilization study of retinoic acid employing some bile salts 96
Serum, urine and peritoneal fluid levels of 5-FU following intraperitoneal administration. 93
Complessazione dell’acido retinoico mediante sali di acidi biliari: caratterizzazione chimico-fisica e valutazione dell’efficacia antiproliferativa su colture cellulari 90
Preformulative study of liposomes containing retinoic acid 90
Mucoadesive polymeric films and reservoir devices for transmucosal drug delivery. 86
Rivestimento con film polimerici di forme di dosaggio buccoadesive 82
FUNCTIONAL INTERACTIONS BETWEEN ALL TRANS RETINOIC ACID AND BILE SALTS ON CELL PROLIFERATION. 79
Studio di solubilizzazione dell’acido retinoico mediante l’impiego di alcuni sali biliari 78
Piroxicam loaded spray dried microspheres as carrier in controlled drug delivery. 77
Interazione fra acido tolfenamico e poloxamero 407 e studio di rilascio da geli 75
Formulazione bioadesiva per somministrazione boccale di Ossicodone cloridrato 75
Synthesis and Antitumor Activity of a New Cis-Diammineplatinum(II) Complex Containing Procaine Hydrocloride 75
Sviluppo di due forme farmaceutiche solide contenenti la forma triclina dell'acido retinoico. 74
Mucoadhesive polymeric films and reservoir devices for transmucosal drug delivery 74
Protein loaded nanoparticles made of cross-linked high amylose starch and N-trimethyl glicol chitosan 72
Tolfenamic acid gels based on poloxamer 407. Evaluation by a mixture experimental design 71
Polyphenolische Verbindungen aus Quercus ilex L. 69
Interazione fra Antralina e ciclodestrine 68
Formulation and in vitro Evaluation of Bioadhesive Films for Buccal Drug administration. 67
Studio di caratterizzazione del polimorfismo dell’acido retinoico. 66
Nanoparticelle: loro proprietà e prospettive per l'uso in medicina 63
Studio preliminare di modifica di rilascio del diltiazem da compresse ottenute per compressione diretta. 59
Stability indicating TLC for retinoic acid in hard gelatine capsules containing lactose and as bulk drug substance 57
INVESTIGATIONAL STUDY ON AN INNOVATIVE MATRIX FOR EXTENDED DRUG RELEASE OBTAINED BY SUBMITTING TO A THERMAL TREATMENT TABLETS PRODUCED BY DIRECT COMPRESSION 54
Preparation and characterization of cross-linked high amylose starch poloxamer P407 matrices 51
Totale 6.620
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.902
article - articoli 8.493
book - libri 0
conference - conferenze 9.156
curatela - curatele 0
other - altro 0
patent - brevetti 3.253
selected - selezionate 0
volume - volumi 0
Totale 41.804
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021172 0 0 0 10 6 29 8 10 31 13 36 29
2021/2022717 9 77 59 96 15 27 48 186 28 65 16 91
2022/2023760 84 48 7 111 115 151 4 52 127 6 48 7
2023/2024426 19 51 7 62 26 146 26 18 17 3 21 30
2024/20251.024 54 79 25 75 150 111 81 174 37 41 87 110
2025/2026442 213 41 79 109 0 0 0 0 0 0 0 0
Totale 6.620